TailorMed Acquires Vivor

Vivo Infusion Acquires Specialty Infusion

June 20, 2023

Healthcare Services

Vivo Infusion, a national provider of community-based ambulatory infusion and injection care, has acquired Specialty Infusion, a provider of ambulatory infusion and specialty pharmacy services operating 14 centers across New York, Massachusetts, and New Jersey. The deal expands Vivo's footprint to a combined 55 ambulatory infusion centers across ten states; financial terms were not disclosed.

VitalHub Acquires Novari Health

July 7, 2025

Healthcare Services

VitalHub Corp. has acquired Novari Health Inc., a Kingston-based provider of patient flow and referral management software, for total up-front consideration of $43.6 million plus potential performance-based consideration (up to $5.0 million earnout). The acquisition strengthens VitalHub's patient-flow and referral management capabilities and is expected to accelerate Novari's international expansion leveraging VitalHub's footprint, particularly in the UK.

Health Catalyst Acquires Vitalware

August 11, 2020

Data & Analytics

Health Catalyst, Inc. entered into a definitive agreement to acquire Vitalware, LLC, a Yakima, Washington–based provider of revenue workflow optimization and analytics SaaS for healthcare organizations. Vitalware brings Best in KLAS chargemaster management, revenue integrity, and price transparency solutions that expand Health Catalyst’s CFO offering; the deal is expected to close in Q3–Q4 2020 and will be funded with a mix of stock and cash.

LLR Partners Leads Growth Investment in Viventium

February 7, 2023

Cloud & SaaS

LLR Partners has made a growth capital investment in Viventium, a SaaS-based human capital management and payroll platform focused on post-acute healthcare. Existing investor ABS Capital Partners and Viventium’s founders (the Kohn family) remain shareholders, and the capital will support continued product and customer growth; BMO Capital Markets served as lead financial advisor with KeyBanc as co-advisor.

Vividion Therapeutics Acquires Tavros Therapeutics

January 12, 2025

Biotechnology

Vividion Therapeutics, a wholly owned subsidiary of Bayer AG, has acquired precision oncology platform company Tavros Therapeutics. The acquisition expands Vividion’s functional genomics and genomic screening capabilities, combining Tavros’s platform with Vividion’s chemoproteomics expertise to accelerate discovery of novel targets in oncology and immunology; financial terms were not disclosed.

Inovalon Acquires VigiLanz

February 5, 2024

Healthcare Services

Inovalon, a Bowie, Maryland-based provider of cloud-based healthcare SaaS, has acquired VigiLanz, a SaaS clinical surveillance and patient safety company. The acquisition expands Inovalon’s clinical surveillance and patient-safety capabilities, broadens its customer base, and increases its addressable market in provider and life sciences offerings.